Sucampo Reports Second Quarter 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Sucampo Reports Second Quarter 2016 Financial Results

Mizuho Securities Reiterates Buy on Sucampo Pharma (SCMP) as Amitiza Royalies Drives 2Q Beat

August 3, 2016 9:12 AM EDT

Mizuho Securities reiterated a Buy rating and $14.00 price target on Sucampo Pharmaceuticals (NASDAQ: SCMP) following the company's 2Q earnings report. SCMP reported revenues of $52.0M and $0.23 in EPS vs. consensus of $48.6M and $0.22. The beat was driven primarily by higher royalty revenue from Amitiza... More

Sucampo Pharma (SCMP) Tops Q2 EPS by 1c

August 3, 2016 8:09 AM EDT

Sucampo Pharma (NASDAQ: SCMP) reported Q2 EPS of $0.23, $0.01 better than the analyst estimate of $0.22. Revenue for the quarter came in at $52 million versus the consensus estimate of $48.61 million.

For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.

... More